Characteristics | GLC (n = 79) | Non-GLC (n = 203) | p value | ||
---|---|---|---|---|---|
n | % | n | % | ||
Sex | |||||
Male | 57 | 72.2 | 125 | 61.6 | 0.226 |
Female | 21 | 26.6 | 76 | 37.4 | |
Unknown | 1 | 1.3 | 2 | 1.0 | |
Age groups | |||||
<30 | 16 | 20.3 | 49 | 24.1 | |
30–45 | 46 | 58.2 | 122 | 60.1 | 0.302 |
>45 | 16 | 20.3 | 32 | 15.8 | |
No information | 1 | 1.3 | 0.0 | ||
Treatment regimen | |||||
Regimen 4A | 43 | 54.4 | 1 | 0.5 | |
Regimen 4B | 34 | 43.0 | 0 | 0.0 | |
Others | 1 | 1.3 | 202 | 99.5 | |
No information | 1 | 1.3 | 0 | 0.0 | |
Treatment outcome | |||||
Cured | 62 | 78.5 | 99 | 48.8 | <0.001 |
Completed | 5 | 6.3 | 10 | 4.9 | |
Failure | 2 | 2.5 | 5 | 2.5 | |
Default | 5 | 6.3 | 52 | 25.6 | <0.001 |
Died | 3 | 3.8 | 0 | 0 | |
Transfer-out | 0 | 0 | 2 | 1 | |
Still on treatment | 0 | 0 | 1 | 0.5 | |
Not evaluated | 2 | 2.5 | 34 | 16.8 |